Citation Impact
Citing Papers
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2011 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Human Milk Composition
2012 Standout
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
1997
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Herpes zoster in children with bone marrow transplantation: Report from a single institution
1995
Cytogenetic, Molecular Genetic, and Clinical Characteristics of Acute Myeloid Leukemia With a Complex Karyotype
2008
Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella
2004
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
1996 Standout
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
1995
The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer
2010
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
The DNA damage response pathways: at the crossroad of protein modifications
2007
Treatment of relapse after allogeneic bone marrow transplantation
1996
Recognition and Treatment of Shingles
1994
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
2014
The DNA Damage Response Kinases DNA-dependent Protein Kinase (DNA-PK) and Ataxia Telangiectasia Mutated (ATM) Are Stimulated by Bulky Adduct-containing DNA
2011 StandoutNobel
Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study
2006
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Zona de l'enfant
1998 StandoutNobel
Medication errors in paediatric care: a systematic review of epidemiology and an evaluation of evidence supporting reduction strategy recommendations
2007
Vascular disorders of the liver # †
2008 Standout
Serine/threonine phosphatases in the DNA damage response and cancer
2010
Molecular mechanisms of cisplatin resistance
2011 Standout
Chronic graft-versus-host disease
2003 Standout
DNA Damage, Aging, and Cancer
2009 Standout
Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data
2015 Standout
Classical and Nonclassical HLA Class I Antigen and NK Cell–Activating Ligand Changes in Malignant Cells: Current Challenges and Future Directions
2005
Graft-versus-host disease
2009 Standout
Use of an Inactivated Varicella Vaccine in Recipients of Hematopoietic-Cell Transplants
2002
Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity
1995
Short Courses of Intravenous Empirical Antibiotic Treatment in Selected Febrile Neutropenic Children with Cancer
2002
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs
2010
DNA repair deficiency in neurodegeneration
2011
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
The PI3K Pathway in Human Disease
2017 Standout
Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways
2006
Subclinical Varicella-Zoster Virus Viremia, Herpes Zoster, and T Lymphocyte Immunity to Varicella-Zoster Viral Antigens after Bone Marrow Transplantation
1992
The associations between Parkinson’s disease and cancer: the plot thickens
2015
Erythropoietin and prematurity – where do we stand?
2005
The first 30 years of p53: growing ever more complex
2009 Standout
The Incidence of Zoster after Immunization with Live Attenuated Varicella Vaccine
1991
Penicillin-binding proteins and β-lactam resistance
2008
ATM and ataxia telangiectasia
2004
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
INFECTION IN THE BONE MARROW TRANSPLANT RECIPIENT
1995
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
AmpC β-Lactamases
2009 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Varicella-zoster virus
1996 Standout
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease
1995
Vaccinating HIV patients: focus on human papillomavirus and herpes zoster vaccines.
2013 StandoutNobel
Graft-versus-leukemia effects of transplantation and donor lymphocytes
2008
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
1996
Three Decades of β-Lactamase Inhibitors
2010 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
2008 Standout
Erythropoietin
1991
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of Pierre Wacker being referenced
Early Hospital Discharge of Children with Fever and Neutropenia
1997
Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity
1992
ATM gene and lymphoid malignancies
2003
Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study
1990
Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation
2004
Analysis and quantification of prescribing and transcription errors in a paediatric oncology service.
2002
ATM gene alterations in childhood acute lymphoblastic leukemias
2003
Permeability and penicillin-binding protein alterations in Salmonella muenchen: stepwise resistance acquired during beta-lactam therapy
1989
The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG)
2007
Varicella-zoster virus infections after autologous bone marrow transplantation in children.
1989
Adoptive immunotherapy for recurrent CML after BMT.
1993